News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
334,749 Results
Type
Article (20128)
Company Profile (128)
Press Release (314493)
Multimedia
Podcasts (75)
Webinars (11)
Section
Business (105465)
Career Advice (881)
Deals (18541)
Drug Delivery (97)
Drug Development (50806)
Employer Resources (79)
FDA (7712)
Job Trends (7756)
News (186027)
Policy (17363)
Tag
Academia (736)
Accelerated approval (3)
Adcomms (17)
Allergies (45)
Alliances (27876)
ALS (57)
Alzheimer's disease (643)
Antibody-drug conjugate (ADC) (100)
Approvals (7722)
Artificial intelligence (151)
Autoimmune disease (17)
Automation (6)
Bankruptcy (177)
Best Places to Work (5553)
BIOSECURE Act (13)
Biosimilars (99)
Biotechnology (57)
Bladder cancer (41)
Brain cancer (19)
Breast cancer (116)
Cancer (1138)
Cardiovascular disease (118)
Career advice (715)
Career pathing (21)
CAR-T (56)
Cell therapy (159)
Cervical cancer (6)
Clinical research (42813)
Collaboration (494)
Compensation (188)
Complete response letters (23)
COVID-19 (1102)
CRISPR (26)
C-suite (165)
Cystic fibrosis (60)
Data (1241)
Decentralized trials (2)
Denatured (19)
Depression (27)
Diabetes (148)
Diagnostics (1820)
Digital health (5)
Diversity (7)
Diversity, equity & inclusion (21)
Drug discovery (82)
Drug pricing (115)
Drug shortages (30)
Duchenne muscular dystrophy (63)
Earnings (39365)
Editorial (32)
Employer branding (10)
Employer resources (73)
Events (48882)
Executive appointments (474)
FDA (8387)
Friedreich's ataxia (3)
Frontotemporal dementia (1)
Funding (332)
Gene editing (53)
Generative AI (18)
Gene therapy (154)
GLP-1 (610)
Government (1865)
Grass and pollen (3)
Guidances (71)
Healthcare (5905)
Huntington's disease (14)
IgA nephropathy (21)
Immunology and inflammation (90)
Indications (19)
Infectious disease (1184)
Inflammatory bowel disease (90)
Inflation Reduction Act (8)
Influenza (25)
Intellectual property (58)
Interviews (116)
IPO (7382)
IRA (45)
Job creations (2436)
Job search strategy (648)
Kidney cancer (7)
Labor market (28)
Layoffs (283)
Leadership (16)
Legal (4122)
Liver cancer (32)
Lung cancer (171)
Lymphoma (92)
Machine learning (5)
Management (30)
Manufacturing (230)
MASH (54)
Medical device (1966)
Medtech (1969)
Mergers & acquisitions (11436)
Metabolic disorders (523)
Multiple sclerosis (50)
NASH (20)
Neurodegenerative disease (52)
Neuropsychiatric disorders (23)
Neuroscience (977)
NextGen: Class of 2025 (2358)
Non-profit (908)
Now hiring (23)
Obesity (328)
Opinion (191)
Ovarian cancer (35)
Pain (76)
Pancreatic cancer (42)
Parkinson's disease (87)
Partnered (11)
Patents (155)
Patient recruitment (51)
Peanut (16)
People (33563)
Pharmaceutical (74)
Pharmacy benefit managers (22)
Phase I (13413)
Phase II (18112)
Phase III (14542)
Pipeline (845)
Policy (133)
Postmarket research (1618)
Preclinical (4703)
Press Release (29)
Prostate cancer (65)
Psychedelics (16)
Radiopharmaceuticals (161)
Rare diseases (253)
Real estate (3175)
Recruiting (29)
Regulatory (12609)
Reports (23)
Research institute (820)
Resumes & cover letters (138)
Rett syndrome (1)
RNA editing (2)
RSV (25)
Schizophrenia (63)
Series A (60)
Series B (36)
Service/supplier (7)
Sickle cell disease (37)
Special edition (16)
Spinal muscular atrophy (111)
Sponsored (12)
Startups (2012)
State (2)
Stomach cancer (9)
Supply chain (55)
Tariffs (50)
The Weekly (54)
Vaccines (288)
Venture capitalists (30)
Weight loss (247)
Women's health (14)
Worklife (8)
Date
Today (106)
Last 7 days (471)
Last 30 days (1530)
Last 365 days (16637)
2025 (5989)
2024 (17670)
2023 (19639)
2022 (25865)
2021 (26641)
2020 (24871)
2019 (20058)
2018 (15588)
2017 (17253)
2016 (16202)
2015 (18803)
2014 (14789)
2013 (12554)
2012 (13485)
2011 (13818)
2010 (12738)
Location
Africa (409)
Alabama (23)
Alaska (1)
Arizona (68)
Arkansas (8)
Asia (24970)
Australia (3232)
California (2729)
Canada (1166)
China (350)
Colorado (107)
Connecticut (105)
Delaware (81)
Europe (51622)
Florida (480)
Georgia (59)
Idaho (16)
Illinois (264)
India (20)
Indiana (178)
Iowa (3)
Japan (132)
Kansas (65)
Kentucky (18)
Louisiana (3)
Maine (4)
Maryland (391)
Massachusetts (2301)
Michigan (48)
Minnesota (144)
Mississippi (1)
Missouri (28)
Montana (10)
Nebraska (11)
Nevada (19)
New Hampshire (8)
New Jersey (1100)
New Mexico (21)
New York (798)
North Carolina (527)
North Dakota (2)
Northern California (1166)
Ohio (84)
Oklahoma (5)
Oregon (21)
Pennsylvania (654)
Puerto Rico (12)
Rhode Island (18)
South America (609)
South Carolina (4)
Southern California (1117)
Tennessee (40)
Texas (359)
United States (10879)
Utah (60)
Virginia (92)
Washington D.C. (47)
Washington State (229)
Wisconsin (25)
334,749 Results for "aptar pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aptar Declares Quarterly Dividend
April 18, 2025
·
1 min read
BioMidwest
Aptar Pharma Continues Global Expansion with North America Capacity Extension at Congers, New York Site
Aptar Pharma today announced the next phase of its global capacity expansion plan in North America, at its Aptar Congers, New York site.
March 14, 2024
·
4 min read
Press Releases
Aptar Reports Fourth Quarter and Annual 2024 Results
February 6, 2025
·
19 min read
Press Releases
Aptar Announces Clinical Validation Study to Accelerate US FDA Approval of SmartTrack™ In-Vitro-in-Silico Platform for Pressurized Metered-Dose Inhalers
April 16, 2025
·
4 min read
Press Releases
Aptar Pharma Enters into Exclusive Agreement with Cambridge Healthcare Innovations to Commercialize the Quattrii Dry Powder Inhaler Platform
November 8, 2024
·
3 min read
Press Releases
Aptar Pharma Acquires Device Technology Assets of SipNose to Further Expand Intranasal Drug Delivery Portfolio
October 9, 2024
·
2 min read
Press Releases
Aptar Declares Quarterly Dividend and Announces 2025 Annual Meeting Details
January 23, 2025
·
2 min read
Press Releases
Aptar to Present at 43rd Annual J.P. Morgan Healthcare Conference on January 16, 2025
January 7, 2025
·
2 min read
Business
Aptar Digital Health and Iona Mind Announce Partnership to Deliver Scalable Mental Health Support to Chronic Disease Patients
Aptar Digital Health today announced a partnership to help support patients with chronic diseases to manage their psychological stress and emotional wellbeing.
May 29, 2024
·
5 min read
FDA
Aptar’s N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA’s Emerging Technology Program
September 23, 2024
·
5 min read
1 of 33,475
Next
